{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:27:31Z","timestamp":1768710451201,"version":"3.49.0"},"reference-count":70,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"This manuscript has not been funded."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/14656566.2022.2029409","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T07:34:18Z","timestamp":1643096058000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["An up-to-date evaluation of dolutegravir\/abacavir\/lamivudine for the treatment of HIV"],"prefix":"10.1080","volume":"23","author":[{"given":"Brandon L","family":"Christensen","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell HS","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Infectious Diseases, St Michael\u2019s Hospital, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"e_1_3_3_3_1","unstructured":"Canadian Pharmacists Association. CPS: TRIUMEQ [Product Monograph] [Internet]. [cited 2021 Aug 28]. Available from: http:\/\/www.e-therapeutics.ca."},{"key":"e_1_3_3_4_1","unstructured":"Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV [Internet]. [cited 2021 Jul 19]. Available from: iv.gov\/sites\/default\/files\/inline-files\/AdultandAdolescentGL.pdf."},{"key":"e_1_3_3_5_1","unstructured":"European AIDS Clinical Society. ECAS Guidelines [Internet]. 2020 [cited 2021 Aug 28]. p. 1\u2013122. Available from: https:\/\/www.eacsociety.org\/media\/guidelines-10.1_30032021_1.pdf."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17025"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70196-7"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318289545c"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01209-10"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30340-4"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003025"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000147521.34369.c9"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.s1657"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906768"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182282cfc"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0256-y"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.073189"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565020-00010"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283612419"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00157-11"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834a1dd9"},{"key":"e_1_3_3_22_1","first-page":"67","article-title":"Abacavir: a review of its clinical potential in patients with HIV infection","volume":"9","author":"Hervey PS","year":"2000","unstructured":"Hervey PS, Perry CM, Katlama C, et al. Abacavir: a review of its clinical potential in patients with HIV infection. Prescrire Int. 2000;9:67\u201369.","journal-title":"Prescrire Int"},{"issue":"3","key":"e_1_3_3_23_1","first-page":"92","article-title":"Drug resistance mutations in HIV-1","volume":"11","author":"D\u2019Aquila RT","year":"2003","unstructured":"D\u2019Aquila RT, Schapiro JM, Brun-V\u00e9zinet F, et al. Drug resistance mutations in HIV-1. Top HIV Med. 2003;11(3):92\u201396.","journal-title":"Top HIV Med"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.1094"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0360-7"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz256"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa202"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13154"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00292-13"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1577821"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70290-0"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70257-3"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215541"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000790"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60084-2"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00027-2"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30077-3"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30099-0"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis750"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu051"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30036-2"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002533"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx053"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz999"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013016"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30238-1"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz407"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30277-6"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000789"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12468"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12710"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00870-z"},{"key":"e_1_3_3_54_1","first-page":"133","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash R","year":"2010","unstructured":"Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 2010;379:133\u2013151.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905230"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1908155"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103167"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002289"},{"key":"e_1_3_3_59_1","first-page":"1066","volume-title":"AIDS 2020","author":"Zash R","year":"2020","unstructured":"Zash R, Holmes L, and Diseko M, et al. Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana. AIDS 2020, July 6-10, 2020, Virtual. [Internet]. 2020. p. 1066\u20131067. Accessed 18 Dec 2021. Available from: https:\/\/www.aids2020.org\/wp-content\/uploads\/2020\/09\/AIDS2020_Abstracts.pdf"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04440.x"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.66"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1086\/649897"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31826f993c"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418800865"},{"key":"e_1_3_3_65_1","unstructured":"Healthcare V. WORLDWIDE APPROVAL: TRIUMEQ Tablets [Internet]. 2021 [cited 2021 Aug 28]. Available from: https:\/\/viivhealthcare.com\/content\/dam\/cf-viiv\/viiv-healthcare\/en_GB\/files\/triumeq-wwrs-07-Jun-2021-for-external-use.pdf."},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002275"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1243"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1806554"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy228"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy332"},{"key":"e_1_3_3_71_1","first-page":"1","article-title":"Impact of the M184V\/I mutation on the efficacy of abacavir\/lamivudine\/dolutegravir therapy in HIV treatment-experienced patients","volume":"6","author":"Olearo F","year":"2019","unstructured":"Olearo F, Nguyen H, Bonnet F, et al. Impact of the M184V\/I mutation on the efficacy of abacavir\/lamivudine\/dolutegravir therapy in HIV treatment-experienced patients. Open Forum Infect Dis. 2019;6:1\u201312.","journal-title":"Open Forum Infect Dis"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa479"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2029409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:39:58Z","timestamp":1732091998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2029409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/14656566.2022.2029409"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2029409","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}